4-CHLORO-3-(TRIFLUOROMETHYL)-1H-PYRAZOLO[3,4-B]PYRIDINE, 98%, 1g

3-Bromocinnolin-4(1H)-one, 95.0%, 1g

Ethyl 2-Iodopropionate>97.0%(GC)25g

Ester benzylique d'acide salicylique, min.99%, 100 ml, emballage en verre

1-[2-(3-Trifluoromethyl-phenyl)-thiazol-4-yl]-ethanone, 95.0%, 1g

2-amino-N,N-diphenylacetamide hydrochloride, 95.0%, 500mg

2-Chloro-6-methylquinoline-3-carboxylic acid, 98%, 1g

(2E)-1-(2,5-dimethoxyphenyl)-3-(thiophen-2-yl)prop-2-en-1-one, 95.0%, 2g

5,12-Dioxahexacyclo[7.6.1.0~2,8~.0~4,6~.0~10,15~.0~11,13~]hexadecane (mixture of isomers)>98.0%(GC)25g

2',4'-Dimethoxyacetophenone, 98.0%, 500g

2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethoxy)phenol, 95.0%, 250mg

1,1,2-Trimethyl-1H-benzo[e]indole, 95.0%, 25g

6,7-Dihydro-4H-pyrano[4,3-d]thiazol-2-amine, 95.0%, 5g